Form 4: Amgen SVP Rachna Khosla Reports Stock Disposal

Amgen's SVP of Business Development, Rachna Khosla, reported the disposal of 489 shares of common stock to cover tax obligations.

Summary

• On March 17, 2025, Rachna Khosla, SVP of Business Development at Amgen Inc., disposed of 489 shares of Amgen common stock.
• The transaction was executed at a price of $313.71 per share.
• This disposal was related to tax obligations.
• Following the transaction, Khosla directly owns 9,340 shares of Amgen common stock, which includes 162 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment, as it reflects standard compensation and tax management practices.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This particular filing reflects a common practice of executives selling shares to cover tax obligations related to equity compensation.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, as it is a relatively small number of shares being disposed of by a single executive.

Key Dates

Keywords

Form 4, Amgen, Rachna Khosla, Stock Disposal, Beneficial Ownership, SVP Business Development, Dividend Equivalents